Biochemical and transcriptomic evaluation of a 3D lung organoid platform for pre-clinical testing of active substances targeting senescence.

Authors:
Brand M; Ritzmann F; Kattler K; Milasius D; Yao Y and 6 more

Journal:
Respir Res

Publication Year: 2024

DOI:
10.1186/s12931-023-02636-7

PMCID:
PMC10765931

PMID:
38172839

Journal Information

Full Title: Respir Res

Abbreviation: Respir Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe protocol for isolation of basal cells was approved by the Institutional Review Board (ethics committee, Nr- 34/18) of the Saarland State Medical Association and informed consent was obtained from the patients. Consent for publicationNot applicable. Competing interestsRobert Bals is the Editor-in-Chief of Respiratory Research starting from Feb 1st 2020. Competing interests Robert Bals is the Editor-in-Chief of Respiratory Research starting from Feb 1st 2020."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. This study was supported by the German Federal Ministry of Education and Research (BMBF in the call “Alternative methods to animal experiments” (project 3-REPLACE, 16LW0140K) to CB, DY, R.B. and RM. Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025